Literature DB >> 15701065

A brief measure of high nicotine dependence for busy clinicians and large epidemiological surveys.

Francisco J Diaz1, Mireia Jané, Esteve Saltó, Hélios Pardell, Lluís Salleras, Cristina Pinet, Jose de Leon.   

Abstract

OBJECTIVE: It is important to perform a routine screening of nicotine dependence in psychiatric patients. The Fagerstrom Test for Nicotine Dependence (FTND) is a widely used six-item questionnaire. The Heavy Smoking Index (HSI) is a briefer measure including only two FTND items (time to first cigarette of day and number of daily cigarettes). In a prior study comparing HSI with FTND, a high HSI (score > or = 4) was a good and briefer alternative for detecting high nicotine dependence. The goals of this study were: (i) to compare the effectiveness of the HSI with the effectiveness of Items 1 and 4 alone for the screening of high nicotine dependence; (ii) to investigate the optimality of 4 as a cut-off score for the HSI so that the HSI can be used as a binary indicator of high nicotine dependence; and (iii) to compare the sensitivity and specificity of four indexes of high nicotine dependence, namely 'High HSI', 'Very Early Smoking', 'Heavy Smoking' and 'High in Either Item'.
METHOD: The FTND was administered to 819 current daily smokers from a general population survey. As in a prior study, an FTND score > or = 6 was considered the reference or 'gold standard' test for detecting high nicotine dependence. Receiver-operating characteristic analyses were performed.
RESULTS: This new study using more sophisticated statistical methodology verified that a cut-off of 4 for the HSI is appropriate and that the 'high' HSI has good sensitivity and specificity even across different population subclassifications.
CONCLUSIONS: With four questions (smoking, daily smoking, time to first cigarette of day and number of daily cigarettes) and minimal calculations, it may be possible to screen whether a smoker has high nicotine dependence. If other studies in other populations and settings verify this finding, this brief measure might be an ideal screening instrument for busy clinicians, epidemiologists developing questionnaires for health surveys and psychiatric researchers.

Entities:  

Mesh:

Year:  2005        PMID: 15701065     DOI: 10.1080/j.1440-1614.2005.01538.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  23 in total

1.  Smoking cessation in patients with psychiatric disorders.

Authors:  Alan J Gelenberg; Jose de Leon; A Eden Evins; Joseph J Parks; Nancy A Rigotti
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

2.  Relationship between Tobacco Use and Health-Related Quality of Life (HRQoL) among Clients in Substance Use Disorders Treatment.

Authors:  Barbara Campbell; Deborah Yip; Thao Le; Noah Gubner; Joseph Guydish
Journal:  J Psychoactive Drugs       Date:  2018-12-20

3.  Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST.

Authors:  R P Schwartz; J McNeely; L T Wu; G Sharma; A Wahle; C Cushing; C D Nordeck; A Sharma; K E O'Grady; J Gryczynski; S G Mitchell; R L Ali; J Marsden; G A Subramaniam
Journal:  J Subst Abuse Treat       Date:  2017-01-31

4.  Contribution of parental psychopathology to offspring smoking and nicotine dependence in a genetically informative design.

Authors:  Hong Xian; Jeffrey F Scherrer; Michele L Pergadia; Pamela A F Madden; Julia D Grant; Carolyn E Sartor; Jon Randolph Haber; Theodore Jacob; Kathleen K Bucholz
Journal:  J Stud Alcohol Drugs       Date:  2010-09       Impact factor: 2.582

Review 5.  Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings.

Authors:  Jose de Leon; Francisco J Diaz
Journal:  Hum Genet       Date:  2011-12-22       Impact factor: 4.132

6.  Design of NIDA CTN Protocol 0047: screening, motivational assessment, referral, and treatment in emergency departments (SMART-ED).

Authors:  Michael P Bogenschutz; Dennis M Donovan; Bryon Adinoff; Cameron Crandall; Alyssa A Forcehimes; Robert Lindblad; Raul N Mandler; Neal L Oden; Harold I Perl; Robrina Walker
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

7.  Suicidal behavior, smoking, and familial vulnerability.

Authors:  Jeffrey F Scherrer; Julia D Grant; Arpana Agrawal; Pamela A F Madden; Qiang Fu; Theodore Jacob; Kathleen K Bucholz; Hong Xian
Journal:  Nicotine Tob Res       Date:  2011-11-11       Impact factor: 4.244

8.  Lessons learned for follow-up phone booster counseling calls with substance abusing emergency department patients.

Authors:  Dennis M Donovan; Mary A Hatch-Maillette; Melissa M Phares; Ernest McGarry; K Michelle Peavy; Julie Taborsky
Journal:  J Subst Abuse Treat       Date:  2014-11-05

9.  Correlates of lifetime blunt/spliff use among cigarette smokers in substance use disorders treatment.

Authors:  Barbara K Campbell; Thao Le; Kwinoja Kapiteni; Noah R Gubner; Joseph Guydish
Journal:  J Subst Abuse Treat       Date:  2020-06-26

10.  Fagerstrom test for nicotine dependence vs heavy smoking index in a general population survey.

Authors:  M Pérez-Ríos; M I Santiago-Pérez; B Alonso; A Malvar; X Hervada; J de Leon
Journal:  BMC Public Health       Date:  2009-12-30       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.